Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts ANVS Hot Sheet
Join SI Premium – FREE
Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
